Technical Analysis for ERAS - Erasca, Inc

Grade Last Price % Change Price Change
D 19.42 -5.77% -1.19
ERAS closed down 5.77 percent on Friday, September 17, 2021, on 7.34 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Down
Historical ERAS trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Multiple of Ten Bearish Other 0.00%
Outside Day Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish -5.77%
1,2,3 Retracement Bearish Bearish Swing Setup -5.77%
Spinning Top Other -5.77%
Older End-of-Day Signals for ERAS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of NSCLC, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. The company was incorporated in 2018 and is headquartered in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Acute Myeloid Leukemia Enzymes Colorectal Cancer Tyrosine Kinase Receptors Oncogenes Bemcentinib Nsclc Non Small Cell Lung Carcinoma Metastatic Solid Tumors Ptpn11 Ras Gtpase

Is ERAS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.47
52 Week Low 14.51
Average Volume 453,818
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 21.81
10-Day Moving Average 21.15
Average True Range 1.62
ADX 31.12
+DI 12.45
-DI 19.20
Chandelier Exit (Long, 3 ATRs) 19.62
Chandelier Exit (Short, 3 ATRs) 23.66
Upper Bollinger Bands 24.60
Lower Bollinger Band 19.01
Percent B (%b) 0.07
BandWidth 25.62
MACD Line -0.09
MACD Signal Line 0.29
MACD Histogram -0.3779
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.30
Resistance 3 (R3) 24.80 23.69 23.48
Resistance 2 (R2) 23.69 22.45 23.43 23.21
Resistance 1 (R1) 21.55 21.68 21.00 21.05 22.94
Pivot Point 20.44 20.44 20.16 20.18 20.44
Support 1 (S1) 18.30 19.20 17.75 17.80 15.90
Support 2 (S2) 17.19 18.43 16.93 15.63
Support 3 (S3) 15.05 17.19 15.36
Support 4 (S4) 14.55